(4S)-2,3-Diazabicyclo[3.1.1]heptane-4-carboxylic Acid Methyl Ester Hydrochloride | CAS 3104671-22-6

Product Details

CasNo： 3104671-22-6

Molecular Formula： C7H12N2O2·HCl

Appearance： White to off-white crystalline powder

Delivery Time： Confirmed according to order quantity, target specification, and current supply availability

Packing： 1 g / 5 g / 10 g / 100 g / 1 kg sealed package, customized packaging available

Throughput： Evaluated based on project requirements, specifications, and order quantity

Purity： ≥98%

Product Introduction

(4S)-2,3-Diazabicyclo[3.1.1]heptane-4-carboxylic acid methyl ester hydrochloride is a chiral bicyclic heterocyclic intermediate featuring a rigid diazabicyclo[3.1.1]heptane scaffold.

With its defined (4S)-stereochemistry and hydrochloride salt form, this compound serves as an advanced building block for medicinal chemistry research, small molecule synthesis, and pharmaceutical intermediate development.

Shandong Juntai Pharmaceutical provides professional synthesis and customization services for advanced pharmaceutical intermediates, supporting research projects and process development requirements.

---

Basic Information

Item	Information
Product Name	(4S)-2,3-Diazabicyclo[3.1.1]heptane-4-carboxylic Acid Methyl Ester Hydrochloride
CAS Number	3104671-22-6
Molecular Formula	C₇H₁₂N₂O₂·HCl
Molecular Weight	192.64 g/mol
Product Type	Chiral Heterocyclic Pharmaceutical Intermediate
Appearance	White to off-white crystalline powder
Salt Form	Hydrochloride salt
Storage Condition	Store in a cool, dry place and protect from moisture and direct sunlight

---

Product Features

Chiral Bicyclic Heterocyclic Scaffold

This compound contains a rigid diazabicyclo[3.1.1]heptane framework with defined stereochemistry, providing a valuable structural element for synthetic chemistry and medicinal chemistry studies.

Defined (4S)-Stereochemistry

The controlled stereochemical configuration makes it suitable for applications requiring chiral building blocks during small molecule synthesis and structure optimization.

Advanced Pharmaceutical Building Block

The unique bridged bicyclic structure offers researchers a useful molecular scaffold for developing and evaluating novel small molecule candidates.

---

Research Applications

Medicinal Chemistry Research

(4S)-2,3-Diazabicyclo[3.1.1]heptane-4-carboxylic acid methyl ester hydrochloride can be used as a chiral intermediate in medicinal chemistry research, supporting the design and synthesis of structurally diverse small molecules.

Small Molecule Synthesis

The bicyclic heterocyclic structure provides a valuable building block for synthetic routes involving nitrogen-containing compounds.

Pharmaceutical Intermediate Development

This compound is suitable for research and process development activities involving advanced pharmaceutical intermediates and custom synthesis projects.

---

Custom Synthesis Support

Shandong Juntai Pharmaceutical offers customized synthesis services for pharmaceutical intermediates, including:

• Route optimization
• Process development
• Scale-up synthesis
• Customized intermediate production

Our experienced R&D team supports customers with flexible solutions for different research and development requirements.

---

FAQ

What is the main application of this compound?

This compound is mainly used as a chiral heterocyclic intermediate and building block for medicinal chemistry research and small molecule synthesis.

Is this product an API?

No. This product is not an active pharmaceutical ingredient (API). It is an advanced pharmaceutical intermediate used in chemical synthesis and research applications.

What documents can be provided?

COA, analytical data, and related product documentation can be provided according to customer requirements.

What packaging options are available?

Packaging can be customized according to quantity requirements, including laboratory-scale and larger research project quantities.

Can Juntai provide custom synthesis services?

Yes. Juntai Pharmaceutical provides custom synthesis and process development services for advanced pharmaceutical intermediates.